Timing of Endoscopy in Cirrhotic Patients with Acute Variceal Bleeding
General Hospital of Shenyang Military Region
368 participants
Sep 4, 2024
INTERVENTIONAL
Summary
Endoscopy is important for the diagnosis and treatment of acute upper gastrointestinal bleeding (AUGIB), especially acute variceal bleeding (AVB), in patients with liver cirrhosis. However, the optimal timing of endoscopy remains controversial, primarily because the currently available evidence is of poor quality, and the definition of early endoscopy is also very heterogeneous among studies. Herein, a multicenter randomized controlled trial (RCT) is performed to explore the impact of timing of endoscopy on the outcomes of cirrhotic patients with AVB.
Eligibility
Inclusion Criteria4
- patients with AUGIB which is highly suspected to be caused by gastroesophageal variceal rupture;
- patients with a diagnosis of liver cirrhosis based on imaging and pathology;
- patients and/or their relatives who sign informed consents;
- patients' age ≥18 years.
Exclusion Criteria7
- patients who have undergone endoscopy at other hospitals before admissions;
- patients' hemodynamics are unstable after resuscitation;
- patients with severe cardiovascular or cerebrovascular diseases or renal injury;
- patients who have taken anticoagulants or antiplatelet drugs within 2 weeks before admissions, or are diagnosed with severe hematological diseases;
- patients with human immunodeficiency virus or other acquired or congenital immune deficiency diseases;
- patients with mental illness;
- pregnancy.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
Endoscopy
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT06031402